1 The role of skeletal muscle microsomes as a site of extrahepatic xenobiotic metabolism using n-hexane as a model substrate was investigated. The observed cytochrome P450-dependent metabolism was com pared with that found with liver, and brain micro somal fractions.
2 Rat skeletal muscle microsomes metabolised n-hexane to 1-, 2- and 3-hexanol at rates 40 - 300 times lower than observed with rat liver microsomes.
3 Fast-twitch extensor digitorum longus muscle (EDL) microsomes had twice as much n-hexane hydroxylase activity as the slow-twitch soleus and furthermore the EDL microsomes produced 2-hexanol, a bioactivation product of n-hexane, as a major metabolite.
4 Metabolism of hexane to 1-, 2- and 3- hexanol and 2- hexanone was demonstrated in cultured rat myoblasts.
5 Ethoxyresorufin and pentoxyresorufin O-dealkylation were not detected in either muscle microsomes or myoblasts although immunocytochemical localisation studies were suggestive of the presence of cytochrome P-450.
6 In conclusion, rat skeletal muscle has a low level of xenobiotic metabolism activity. The relevance to neuromuscular toxicity of n-hexane is discussed.
Spencer PS, Schaumburg HH, Sabri MI, Veronesi B.The enlarging view of hexacarbon neurotoxicity. CRC Critical Reviews of Toxicology1980; 7: 279-356.
2.
Towfighi J. et al. Glue sniffer's neuropathy. Neurology1976; 26: 238-43.
3.
Scelsi R., Poggi P., Fera L., Gonella G.Toxic polyneuropathy due to n-hexane. Journal of the NeurologicalSciences1980; 47: 7-19.
4.
Couri D., Milks M.Toxicity and metabolism of the neurotoxic hexacarbons n-hexane, 2-hexanone and 2,5-hexanedione. Annual Review of Pharmacology and Toxicology1982; 22: 145-66.
5.
Bastone A. et al. Cholinesterases in blood plasma and tissues of rats treated with n-hexane or with its neurotoxic metabolite 2,5-hexanedione. Archives of Toxicology1987; 61: 138-44.
6.
Braun M., Haydon DA, Murrell RDThe effects of n-alcohols on the nicotinic acetylcholine receptor channel in cultured rat myotubes. Journal of Physiology-London1989; 418: 37P.
7.
Huang J. et al. Effects of chronic n-hexane exposure on nervous system-specific and muscle-specific proteins. Archives of Toxicology1989; 63: 381-5.
8.
Hawthorn MH et al. Effect of an homologous series of aliphatic alcohols on neuronal and smooth muscle voltage-dependent Ca2+ channels. European Journal of Pharmacology1992; 229: 143-8.
9.
Toftgård R., Haaparanta T., Eng L., Halpert J.Rat lung and liver microsomal cytochrome P-450 isozymes involved in the hydroxylation of n-hexane. Biochemical Pharmacology1986 ; 35: 3733-8.
10.
Battershill JM, Illing Hpa, Shillaker RO, Smith AMn-Hexane. Health & Safety Executive Toxicity Review18, HMSO1987.
11.
Serabjit-Singh CJ, Bend JR, Philpot RMCytochrome P-450 monooxygenase system. Localisation in smooth muscle of rabbit aorta. Molecular Pharmacology1985; 28: 72-9.
12.
Crosbie SJ, Blain PG, Williams FMMetabolism of n-hexane by rat liver and extrahepatic tissues and the effect of cytochromes P-450 inducers. Human and Experimental Toxicology1997; in press.
13.
Veronesi B., Peterson ER, Spencer PSReproduction and analysis of methyl n-butyl ketone neuropathy in organotypic tissue culture. Experimental and Clinical Neurotoxicology. Editors, Spencer PS, Schaumburg HH. Williams and Wilkins, Baltimore/London. 1980.
14.
Lowry OH, Roseborough NJ, Farr AL, Randall RJProtein measurement with the Folin phenol reagent. Journal of Biological Chemistry1951; 193: 265-75.
15.
Blau HM, Webster C.Isolation and characterisation of human muscle cells. Proceedings of the National Academy of Sciences USA1981; 79: 5623-7.
16.
Knudsen KACell adhesion molecules in myogenesis. Current Opinions in CellBiology1990; 2: 902-6.
17.
Burke MD, Mayer RTEthoxyresorufin in direct fluorometric assay of a microsomal O-deethylation which is preferentially inducible by 3-methylchlanthrene. Drug Metabolism and Disposition1974; 2: 583-8.
18.
Rettie AE, Williams FM, Rawlins MD, Burke MDMajor differences between lung, skin and liver in the microsomal metabolism of a homologous series of phenoxazone and coumarin ethers. Biochemical Pharmacology1986; 35: 3495 - 500.
19.
Gasnier F. et al. Investigation of glycosilation processes in mitochondria and microsomal membranes from human skeletal muscle. Clinica Chimica Acta1991; 199: 69-82.
20.
McCallum GP , Horton JE, Falkner KC, Bend JRMicrosomal cytochrome P-450 1A1 dependent monooxygenase activity in guinea pig heart: induction, inhibition and increased activity by addition of exogenous NADPH-cytochrome P-450 reductase. Canadian Journal of Physiology and Pharmacology1992; 71: 151-6.
21.
Stryer L.Biochemistry. 2nd edition. WH Freeman and Company, New York. 1981 .
22.
Reiners, Jr. JJ, Cantu AR, Pavone A.Modulation of constitutive cytochrome P-450 expression in vivo and in vitro in murine keratinocytes as a function of differentiation and extracellular Ca2+ concentration. Proceedings of the National Academy of Sciences USA1990; 87: 1825-9.
23.
Guo J-F., Brown R., Rothwell CE, Bernstein IALevels of cytochrome P-450-mediated aryl hydrocarbon hydroxylase (AHH) are higher in differentiated than in germinative cutaneous keratinocytes. Journal of Investigative Dermatology, 1990; 94: 86-93.
24.
Alvarez J., Montero M., Garcia-Sancho J.Cytochrome P-450 may regulate plasma membrane Ca2+ permeability according to the filling state of the intracellular Ca2+ stores. FASEB Journal1992; 6: 786 -92.
25.
Livingstone I., Johnson MA, Mastaglia FLEffects of dexamthasone on fibre subtype in rat muscle. Neuropathology and Applied Neurobiology1981; 7: 381- 98.
